期刊文献+

帕金森病患者血清一氧化氮、胰岛素样生长因子1及S-100B蛋白水平关系的研究 被引量:11

The relationship of NO,IGF-1 and S-100B protein in patients with Parkinsons disease
暂未订购
导出
摘要 目的观察帕金森病患者血清中一氧化氮(NO)、胰岛素样生长因子1(IGF-1)和S-100B蛋白的水平及关系。方法选取112例帕金森病患者作为观察组,依病变程度分为轻度37例、中度45例,重度30例。选择体检证实为健康的成年人70例作为健康对照组,检测2组血清NO、IGF-1和S-100 B的水平,并进行比较。结果观察组血清NO、S-100B水平均明显高于健康对照组[分别为(5.92±1.45)μmol/L vs.(3.80±1.65)μmol/L,(80.57±16.20)ng/L vs.(67.54±22.41)ng/L],而IGF-1水平显著低于健康对照组[(138.14±35.46)mg/ml vs.(168.73±39.75)mg/ml]。观察组随着病变程度加重,NO、S-100B水平升高、IGF-1水平下降,两两比较差异均有统计学意义(P<0.05)。观察组NO、IGF-1和S-100B水平未见相关性。结论帕金森病患者血清中NO、IGF-1和S-100 B的异常表达对促进患者病程的进展可能有一定作用。 Objective To investigate the expression of NO,IGF-1 and S-100B in patients with Parkinson's disease.Methods Selected 112 cases of Parkinson.disease as the observation group,according to severity as mild in 37 cases,mode rate in 45 cases,30 cases of severe.Select examination confirmed 70 cases of healthy adults as a healthy control group,serum NO,IGF-1 and S-100B level were tested and compared.Results In the observation group,serum NO,S-1008 were significandy higher than healthy controls[(5.92±1.45)μmol/L vs.(3.80±1.65)μmol/L,(80.57±16.20)ng/L vs.(67.54±22.41)ng/L],while IGF-1 levels were significantly lower than the healthy control group[(138.14±35.46)mg/ml vs(168.73±39.75)mg/ml].As the lesions in observed group aggravation,NO,S-100B levels increased,IGF-1 level dropped,pairwise comparisons were statistically significant differences(P0.05).In observation group,NO,IGF-1and S-I00B level showed no correlation.Conclusion Parkinson's diseases patients' serum NO,IGF-1 and S-1008 abnormal expression have a certain effect in promoting the progression of disease.
作者 黄嵘 王翀
出处 《疑难病杂志》 CAS 2014年第1期40-41,58,共3页 Chinese Journal of Difficult and Complicated Cases
关键词 帕金森病 一氧化氮 胰岛素样生长因子1 S-100B蛋白 Parkinson disease NO IGF-1 S-100B protein
  • 相关文献

参考文献10

二级参考文献68

共引文献18

同被引文献120

  • 1柳青.奥拉西坦对脑梗死老年患者血清中S100β蛋白和肿瘤坏死因子-α含量的影响[J].中国老年学杂志,2014,34(6):1676-1677. 被引量:7
  • 2赵仁亮,王春霞.原发性帕金森病患者血浆IGF-1检测的临床意义[J].山东医药,2003,43(23):4-5. 被引量:5
  • 3万婷玉,张巧俊,袁海峰,赵英贤,吴仲恒,李建刚.急性脑梗死患者血清S100β蛋白和C反应蛋白含量变化的研究[J].临床神经病学杂志,2007,20(1):56-58. 被引量:18
  • 4贾建平.神经病学[M].北京:人民卫生出版社,2008,420
  • 5Grosset K,Needleman F,Macphee C,et al.Switching form ergot to non-ergot dopamine agonists in Parkinson's disease:a clonical series and five-drug dose conversion table[J].Mov Disord,2004,19(11):1370-1372.
  • 6朱晓莹.美多巴治疗帕金森病出现On-Off现象1例报告[J].中国煤炭工业医学杂志,2000,3(12):1 233.
  • 7Valenca GT,Class PC,Negreiros NN,et al.Past smoking and cuneni dopamine agonist use shew an Independent and dose-dependent association witb impulse control disorders in Parkinson's disease[J].Parkinsonism Relat Disord,2013,19(7):698-700.
  • 8Perez Lloret S,Rascol O.Pramipexole extended-release(once-daily formulation)for the treatment of Parkinson's disease[J].Expert Opin Pharmacother,2010,1 i(13):2221-2230.
  • 9Dohm CP,Gr(a|¨)schel S,Liman J,et al.Dropped head sign induced by transdermal application of the dopamine agonist rotigotine in parkinsonian syndrome:a ease report[J].J Med Case Rep,2013,7(1):174.
  • 10Hu J, Ferreira A, Van Eldik LJ. S100beta induces neu- ronal cell death through nitric oxide release from astrocytes[J]. J Neurochem 1997, 69(6) : 2294.

引证文献11

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部